Barclays PLC Dice Therapeutics, Inc. Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$25.86 - $46.71 $430,698 - $777,955	16,655 Added 78.13%	37,971 $1.76 Million
Q1 2023 May 04, 2023	BUY	$26.05 - $32.31 $213,062 - $264,263	8,179 Added 62.26%	21,316 $611,000
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $141,968 - $303,253	7,181 Added 120.57%	13,137 $410,000
Q3 2022 Nov 03, 2022	BUY	$14.97 - $22.65 $67,829 - $102,627	4,531 Added 317.96%	5,956 $120,000
Q2 2022 Aug 12, 2022	SELL	$13.19 - $22.1 $18,940 - $31,735	-1,436 Reduced 50.19%	1,425 $22,000
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $41,598 - $71,582	2,861 New	2,861 $55,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.